Proteolytic inactivation of select proteins in bacterial extracts for improved expression

Patent metadata

Field	Value
Publication number	US-10450353-B2
Application number	US-201715483766-A
Country	US
Kind code	B2
Filing date	Apr 10, 2017
Priority date	Oct 12, 2012
Publication date	Oct 22, 2019
Grant date	Oct 22, 2019

Abstract

The present disclosure provides modified proteins that are capable of being cleaved by the protease OmpT1. The proteins can be modified in an exposed surface motif to incorporate OmpT1 cleavage sites. Also provided are nucleic acids encoding the modified proteins, bacterial cells that express the modified proteins, and cell free synthesis systems containing modified RF1. The disclosure further provides methods for reducing the deleterious activity of a modified protein in a cell free synthesis system by contacting the modified protein with OmpT1. Also provided are methods for reducing RF1 competition at an amber codon in the cell free synthesis system, and methods for expressing a protein in the cell free synthesis system. The modified proteins of the invention can be used to increase the yield of proteins having non-natural amino acids incorporated at an amber codon.

First claim

What is claimed is:

1. A mutant Releasing Factor 1 (RF1) protein, wherein the mutant RF1 protein comprises an amino acid sequence having at least 95% sequence identity to the amino acid sequence of SEQ ID NO: 1, wherein the mutant RF1 protein has activity to recognize a stop codon in an mRNA sequence and terminate translation, wherein the amino acid sequence of the mutant RF1 protein corresponding to amino acids 287-304 of SEQ ID NO: 1 comprises a cleavage site for a wild-type Outer Membrane Protein T1 (OmpT1), wherein the amino acid sequence of the cleavage site for the wild-type OmpT1 comprises an amino acid sequence selected from the group consisting of ARR, ARRG (SEQ ID NO:47), WLAARRGRG (SEQ ID NO:48), and WGGRWARKKGTI (SEQ ID NO:49).

2. The mutant RF1 protein of claim 1 , wherein the amino acid sequence of the cleavage site for the wild-type OmpT1 comprises an amino acid sequence selected from the group consisting of:
QARRGSTRRNLLGSGDRS (SEQ ID NO:26);
QQARRGTRRNLLGSGDRS (SEQ ID NO:27);
QQAARRGRRNLLGSGDRS (SEQ ID NO:28);
QQAEARRGRNLLGSGDRS (SEQ ID NO:29);
QQAEAARRGNLLGSGDRS (SEQ ID NO:30);
QQAEASARRGLLGSGDRS (SEQ ID NO:31);
QQAEASTARRGLGSGDRS (SEQ ID NO:32);
QQAEASTRRARRGSGDRS (SEQ ID NO:34);
QQAEASTRRNARRGGDRS (SEQ ID NO:35);
QQAEASTRRNLARRGDRS (SEQ ID NO:36);
QQAEASTRRNLLARRGRS (SEQ ID NO:37);
QQAEASTRRNLLGARRGS (SEQ ID NO:38);
QQAEASTRRNLLGSARRG (SEQ ID NO:39);
QQAEASTRRNLLGSGARR (SEQ ID NO:40)
QQAWLAARRGRGGSGDRS (SEQ ID NO:41);
QQAEWLAARRGRGSGDRS (SEQ ID NO:42);
QQAEAWLAARRGRGGDRS (SEQ ID NO:43)
QQWGGRWARKKGTIGDRS (SEQ ID NO:44);
QQAWGGRWARKKGTIDRS (SEQ ID NO:45); and
QQAEWGGRWARKKGTIRS (SEQ ID NO:46).

3. A bacterial cell comprising both an OmpT1 and the mutant RF1 protein of claim 1 .

4. A nucleic acid encoding the mutant RF1 protein of claim 1 .

5. A bacterial cell comprising the nucleic acid of claim 4 , wherein the nucleic acid is incorporated into a genome of the bacterial cell.

6. A bacterial cell extract comprising the mutant RF1 protein of claim 1 .

7. A cell free synthesis system comprising in a single reaction mixture:
i) components from a bacterial lysate sufficient to translate a nucleic acid template encoding a protein;
ii) a nucleic acid template encoding a protein of interest and having at least one amber codon;
iii) tRNA complementary to the amber codon; and,
iv) the mutant RF1 protein of claim 1 .

8. The cell free synthesis system of claim 7 , wherein the single reaction mixture further comprises a non-natural amino acid and corresponding amino acid tRNA synthetase, the tRNA synthetase able to charge the tRNA complimentary to the amber codon with the non-natural amino acid.

9. The cell free synthesis system of claim 8 , wherein the system generates ATP via an active oxidative phosphorylation system.

10. The mutant RF1 protein of claim 1 , wherein the wild-type OmpT1 comprises the amino acid sequence of SEQ ID NO: 3.

11. A method for expressing a protein of interest in a bacterial cell-free synthesis system, comprising:
i. combining a nucleic acid template encoding the protein of interest with a bacterial cell free synthesis extract to produce a bacterial cell-free synthesis system, wherein the bacterial cell free synthesis extract comprises the mutant RF1 protein of claim 1 and a wild-type OmpT1;
ii. allowing the mutant RF1 protein to be cleaved by the wild-type OmpT1; and
iii. expressing the protein of interest from the nucleic acid template.

12. A method for preparing a cell free synthesis extract, the method comprising the steps of:
i) culturing OmpT1 positive bacteria comprising the nucleic acid of claim 4 to express the mutant RF1 protein; and
ii) lysing the OmpT1 positive bacteria to create the cell free synthesis extract.

13. The method of claim 12 , wherein the OmpT1 positive bacteria is Escherichia coli.

Assignees

• Sutro Biopharma Inc

Inventors

• Thanos Christopher D
• Murray Christopher J
• Yang Junhao
• Stephenson Heather

Classifications

• G01N30/06

  Preparation · CPC title

• C12Q1/689

  for bacteria · CPC title

• C12Y304/21

  Serine endopeptidases (3.4.21) · CPC title

• C12Q1/686

  Polymerase chain reaction [PCR] · CPC title

• C07K14/245 Primary

  Escherichia (G) · CPC title